BCHT(SH:688276) Xin Lang Cai Jing·2026-01-08 05:36Group 1 - The core point of the news is that Baike Bio's stock price increased by 5.03% to 20.47 CNY per share, with a total market capitalization of 8.468 billion CNY as of the report date [1] - Baike Bio, established on March 4, 2004, specializes in the research, production, and sales of human vaccines, with its main revenue sources being varicella vaccine (116.82%) and influenza vaccine (6.07%) [1] Group 2 - According to fund holdings, the Jin Ying Fund has a significant position in Baike Bio, with the Jin Ying Xin Rui Mixed A Fund (003502) holding 3,137 shares, unchanged from the previous period, representing 0.05% of the fund's net value [2] - The Jin Ying Xin Rui Mixed A Fund was established on December 6, 2016, with a current size of 57.569 million CNY, and has generated a year-to-date return of 0.38% [2] Group 3 - The fund managers of Jin Ying Xin Rui Mixed A are Ni Chao and Long Yuefang, with Ni Chao having a tenure of 10 years and 215 days, managing assets totaling 3.184 billion CNY, and achieving a best return of 156.51% during his tenure [3] - Long Yuefang has a tenure of 8 years and 125 days, managing assets of 9.607 billion CNY, with a best return of 41.61% during his tenure [3]